Format

Send to

Choose Destination
Arch Otolaryngol Head Neck Surg. 1996 Nov;122(11):1195-9.

OK-432 therapy for lymphangiomas.

Author information

1
Department of Otolaryngology, University of Iowa, Iowa City, USA.

Abstract

OBJECTIVE:

To assess the efficacy of OK-432 sclerotherapy in the treatment of lymphangiomas.

DESIGN:

Nonrandomized trial; follow-up, 4 to 29 months.

SETTING:

Academic tertiary referral medical center.

PATIENTS:

Six children with presumed lymphangiomas; age range at initial treatment, 1 month to 7 years 10 months.

INTERVENTION:

Fluoroscopically guided cyst aspiration, cystography, and injection of OK-432.

OUTCOME MEASURES:

Clinical and radiographic comparisons before and after therapy.

RESULTS:

Complete response in 2 macrocystic lymphangiomas; no response in 3 microcystic lymphangiomas; and no response in 1 venous malformation.

CONCLUSION:

OK-432 sclerotherapy may be effective treatment for macrocystic lymphangiomas.

PMID:
8906054
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center